Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-pftt2 Total loading time: 0 Render date: 2024-06-08T12:01:21.497Z Has data issue: false hasContentIssue false

27 - The BMT/SCT pharmacopoeia

Published online by Cambridge University Press:  05 August 2013

By
Jill M. Comeau ,
Reinhold Munker  and
Kerry Atkinson
Edited by
Reinhold Munker ,
Gerhard C. Hildebrandt ,
Hillard M. Lazarus  and
Kerry Atkinson
Reinhold Munker
Affiliation:
Louisiana State University, Shreveport
Gerhard C. Hildebrandt
Affiliation:
University of Utah
Hillard M. Lazarus
Affiliation:
Ireland Cancer Center, Case Western Reserve University Hospital, Cleveland
Kerry Atkinson
Affiliation:
University of Queensland
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
The BMT Data Book
Including Cellular Therapy
 , pp. 411 - 508
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Arns da Cunha, C, Weisdorf, D, Shu, XO, et al. 1998. Early gram-positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis. Bone Marrow Transplant 21: 173–180.CrossRefGoogle ScholarPubMed
Aronoff, GR, Bennett, WM, Berns, JS, et al. 2007. Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children, 5th edn. Philadelphia, PA: American College of Physicians.Google Scholar
Basch, E, Prestrud, AA, Hesketh, PJ, et al. 2011. Antiemetics: American Society of Clinical Oncology Clinical Practice guidelines update. J Clin Oncol 29: 4189–4198.CrossRef
Benson, AB, Ajani, JA, Catalano, RB, et al. 2004. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 22: 2918–2926.CrossRefGoogle ScholarPubMed
Bruns, I, Steidl, U, Kronenwett, R, et al. 2006. A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitor in patients with multiple myeloma. Transfusions 46: 180–185.CrossRefGoogle ScholarPubMed
Brunton, LL, Chabner, BA, & Knollman, BC. 2011. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 12th edn. New York, NY: McGraw-Hill.Google Scholar
Buonomo, A, Nucera, E, & De Pasquale, T. 2011. Tolerability of aztreonam in patients with cell-mediated allergy to beta-lactams. Int Arch Allergy Immunol 155: 155–159.CrossRefGoogle ScholarPubMed
Chin, TW, Loeb, M, & Fong, IW. 1995. Effect of an acidic beverage (coca-cola) on absoption of ketoconazole. Antimicrob Agents Chemother 39: 1671–1675.CrossRefGoogle Scholar
Cordonnier, C, Chevret, S, Legrand, M, et al. 2003. Should immunoglobulin therapy be used in allogeneic stem cell transplantation? A randomized double-blind, dose effect, placebo-controlled, multicenter trial. Ann Int Med 139: 8–18.CrossRefGoogle ScholarPubMed
Cornely, OA, Maertens, J, Winston, DJ, et al. 2007. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356: 348–359.CrossRefGoogle ScholarPubMed
Couriel, D, Saliba, R, Hicks, K, et al. 2004. Tumor necrosis factor-α blockade for the treatment of acute GVHD. Blood 104: 649–654.CrossRefGoogle ScholarPubMed
David, KA & Picus, J. 2005. Evaluating risk factors for the development of ifosfamide encephalopathy. Am J Clin Oncol 28: 277–280.CrossRefGoogle ScholarPubMed
Dix, SP, Wingard, JR, Mullins, RE, et al. 1996. Association of busulfan area under the curve with veno-occlusive disease following BMT. Bone Marrow Transpl 17: 225–230.Google ScholarPubMed
Eberly, AL, Anderson, GD, Bubalo, JS, et al. 2008. Optimal prevention of seizures induced by high-dose busulfan. Pharmacotherapy 28: 1502–1510.CrossRefGoogle ScholarPubMed
Einsele, H, Reusser, P, Bornhauser, M, et al. 2006. Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation. Blood 107: 3002–3008.CrossRefGoogle ScholarPubMed
Epstein, JB, Truelove, EL, Hanson-Huggins, K, et al. 2004. Topical poleyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy. Support Care Cancer 12: 517–525.CrossRefGoogle ScholarPubMed
Floyd, J, Mirza, I, Sachs, B, et al. 2006. Hepatoxicity of chemotherapy. Semin Oncol 33: 50–67.CrossRefGoogle Scholar
Henke, M, Alfonsi, M, Foa, P, et al. 2011. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial. J Clin Oncol 29: 2815-2820.CrossRefGoogle ScholarPubMed
Kantarjian, HM, Hochhaus, A, Saglio, G, et al. 2011. Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial. Lancet Oncol 12: 841–851.CrossRefGoogle ScholarPubMed
Kantarjian, H, Shah, NP, Hochhaus, A, et al. 2010. Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 362: 2260–2270.CrossRefGoogle ScholarPubMed
Katzung, BG. 2007. Basic and Clinical Pharmacology, 10th edn. New York, NY: McGraw Hill Lange.Google Scholar
Keefe, DL. 2001. Anthracycline-induced cardiomyopathy. Semin Oncol 28: S2–S7.CrossRefGoogle ScholarPubMed
Keefe, DM, Schubert, MM, Elting, LS, et al. 2007. Updated clinical practice guidelines for the prevention and treatment of mucositisCancer 109: 820–831.CrossRefGoogle ScholarPubMed
Kintzel, PE & Dorr, RT. 1995. Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function. Cancer Treat Rev 21: 33–64.CrossRefGoogle ScholarPubMed
Krass, I, Bajorek, B, Bagia, M, et al. 1997. An evaluation of three methods used in the prophylaxis of cyclophosphamide-induced haemorrhagic cystitis in bone marrow transplant patients. J Oncol Pharm Pract 3: 193–199.CrossRefGoogle Scholar
Lacy, CF, Armstrong, LL, Goldman, MP, et al. 2011. Drug Information Handbook, 20th edn. Hudson, OH: Lexi-Comp.Google Scholar
Le, QT, Kim, HE, Schneider, CJ, et al. 2011. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study. J Clin Oncol 29: 2808–2814.CrossRefGoogle ScholarPubMed
Lexicomp Up-to-date Website: . [Accessed November and December 2011].
Liu, C, Bayer, A, Cosgrove, SE, et al. 2011. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52: 285–292.CrossRefGoogle Scholar
MacIntyre, N, Crapo, RO, Viegi, G, et al. 2005. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26: 720–735.CrossRefGoogle ScholarPubMed
Marty, FM, Lowry, CM, Cutler, CS, et al. 2006. Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 12: 552–557.CrossRefGoogle ScholarPubMed
Micromedex Healthcare Series Website. . Accessed November and December 2011.
Mielcarek, M, Storer, BE, Boeck, H, et al. 2009. Initial therapy of acute graft-versus-host disease with lose-dose prednisone does not compromise patient outcomes. Blood 113: 2888–2894.CrossRefGoogle Scholar
Moreau, P, Pylypenko, H, Grosicki, S, et al. 2011. Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomized, phase 3, non-inferiority study. Lancet Oncol 12: 431–441.CrossRefGoogle ScholarPubMed
Nasilowska-Adamska, B, Rzepecki, P, & Manko, J. 2007. The influence of palifermin (kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoetic stem cell transplant. Bone Marrow Transplant 40: 983–988.CrossRefGoogle Scholar
O’Brien, S, Ravandi, F, Riehl, T, et al. 2008. Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy. Blood 111: 1816–1819.CrossRefGoogle ScholarPubMed
Pappas, PG, Kauffman, CA, Andes, D, et al. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Disease Society of America. Clin Infect Dis 48: 503–535.CrossRefGoogle Scholar
Patriarca, F, Sperotto, A, Damiani, D, et al. 2004. Infliximab treatment for steroid-refractory acute graft-versus-host disease. Haematologica 89: 1352-1359.Google ScholarPubMed
Paul, M, Yahav, D, Bivas, A, et al. 2010. Anti-pseudomonal beta-lactams for the initial, empirical treatment of febrile neutropenia: comparison of beta lactams. Cochrane Database Syst Rev 10: CD005197.Google Scholar
Pfaller, MA, Diekema, FJ, Messer, SA, et al. 2004. Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. J Clin Microbiol 41: 1440–1146.CrossRefGoogle Scholar
Richardson, P, Linden, E, Revta, C, et al. 2009. Use of defibrotide in the treatment and prevention of neo-occlusive disease. Expert Rev Hematol 2: 365–376.CrossRefGoogle ScholarPubMed
Richardson, PG, Soiffer, RJ, Antin, JH, et al. 2010. Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial. Biol Blood Marrow Transplant 16: 1005–1017.CrossRefGoogle ScholarPubMed
Rosenbeck, LL, Kiel, PJ, Kalsekar, I, et al. 2011 Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation. Biol Blood Marrow Transplant 17: 916–922.CrossRefGoogle ScholarPubMed
Rybak, M, Lomaestro, B, Rotschafer, JC, et al. 2009. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health System Pharm 66: 82–98.CrossRefGoogle Scholar
Scheinberg, P, Nunez, O, Weinstein, B, et al. 2011. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med 365: 430–438.CrossRefGoogle ScholarPubMed
Slattery, JT, Sanders, JE, Buckner, CD, et al. 1995. Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics. Bone Marrow Transpl 16: 31–42.Google ScholarPubMed
Sokos, DR, Berger, M, Lazarus, HM. 2002. Intravenous immunoglobulin: appropriate indications and uses in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 8: 117–130.CrossRefGoogle ScholarPubMed
Tay, J, Tinmouth, A, Fergusson, D, et al. 2007. Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 13: 206–217.CrossRefGoogle ScholarPubMed
Thomas, DA, Faderl, S, Cortes, J, et al. 2004. Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood 130: 4396–4407.CrossRefGoogle Scholar
Tomblyn, M, Chiller, T, Einsele, H, et al. 2009. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 15: 1143–1238.CrossRefGoogle ScholarPubMed
Trifilio, SM, Bennett, CL, Yarnold, PR, et al. 2007. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who received hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant 39: 425–429.CrossRefGoogle ScholarPubMed
Ullmann, AJ, Lipton, JH, Vesole, DH, et al. 2007. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356: 335–347.CrossRefGoogle ScholarPubMed
Urban, AW & Craig, WA. 1997. Daily Dosage of Aminoglycosides. Current Clinical Topics in Infectious Diseases, Vol 17. Malden, MA: Blackwell Science.Google Scholar
US Food and Drug Administration Website: . 2009. [Accessed November 2011].
US Food and Drug Administration Website: . 2011. [Accessed November 2011].
Xhaard, A, Rocha, V, Bueno, B, et al. 2011. Steroid-refractory acute GVHD: lack of long-term improved survival using new generation anticytokine treatment. Biol Blood Marrow Transplant 18: 406–413.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×